Lipocine Current Ratio 2012-2018 | LPCN

Lipocine current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Lipocine Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.02B $0.00B 4.63
2018-09-30 $0.02B $0.00B 7.38
2018-06-30 $0.03B $0.00B 8.88
2018-03-31 $0.03B $0.01B 5.03
2017-12-31 $0.03B $0.01B 3.98
2017-09-30 $0.03B $0.00B 10.52
2017-06-30 $0.03B $0.00B 9.63
2017-03-31 $0.03B $0.00B 11.55
2016-12-31 $0.03B $0.00B 20.52
2016-09-30 $0.03B $0.00B 18.71
2016-06-30 $0.03B $0.00B 12.84
2016-03-31 $0.04B $0.00B 12.90
2015-12-31 $0.05B $0.00B 13.23
2015-09-30 $0.04B $0.00B 19.41
2015-06-30 $0.04B $0.00B 26.52
2015-03-31 $0.03B $0.00B 18.66
2014-12-31 $0.03B $0.00B 17.08
2014-09-30 $0.03B $0.00B 15.54
2014-06-30 $0.04B $0.00B 21.22
2014-03-31 $0.04B $0.00B 28.02
2013-12-31 $0.05B $0.00B 35.86
2013-09-30 $0.04B $0.00B 22.78
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.03
2012-12-31 $0.01B $0.00B 25.71
2012-09-30 $0.00B $0.00B 0.09
2012-06-30 $0.00B $0.00B 0.83
2012-03-31 $0.00B $0.00B 3.70
2011-12-31 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.052B $0.000B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.435B 12.00
Grifols (GRFS) Spain $13.064B 15.83
Ionis Pharmaceuticals (IONS) United States $10.939B 33.92
Jazz Pharmaceuticals (JAZZ) Ireland $7.812B 11.19
Neurocrine Biosciences (NBIX) United States $7.728B 500.53
Sage Therapeutics (SAGE) United States $7.480B 0.00
Tilray (TLRY) United States $6.315B 0.00
Catalent (CTLT) United States $5.892B 24.67
Nektar Therapeutics (NKTR) United States $5.636B 8.99
United Therapeutics (UTHR) United States $5.259B 8.94
FibroGen (FGEN) United States $4.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.207B 13.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.128B 21.94
Zogenix (ZGNX) United States $2.204B 0.00
PTC Therapeutics (PTCT) United States $2.183B 0.00
Portola Pharmaceuticals (PTLA) United States $2.143B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.126B 0.00
Aerie Pharmaceuticals (AERI) United States $2.069B 0.00
USANA Health Sciences (USNA) United States $2.028B 17.01
Madrigal Pharmaceuticals (MDGL) United States $2.015B 0.00
Endo (ENDP) Ireland $1.854B 2.86
Enanta Pharmaceuticals (ENTA) United States $1.846B 22.99
Heron Therapeutics (HRTX) United States $1.810B 0.00
Xencor (XNCR) United States $1.735B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.702B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.566B 135.68
Theravance Biopharma (TBPH) Cayman Islands $1.288B 0.00
Corcept Therapeutics (CORT) United States $1.263B 18.35
TherapeuticsMD (TXMD) United States $1.208B 0.00
Esperion Therapeutics (ESPR) United States $1.117B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.088B 0.00
Tricida (TCDA) United States $0.974B 0.00
Radius Health (RDUS) United States $0.843B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.825B 0.00
Dermira (DERM) United States $0.745B 0.00
ChemoCentryx (CCXI) United States $0.614B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.602B 0.00
GlycoMimetics (GLYC) United States $0.575B 0.00
Odonate Therapeutics (ODT) United States $0.569B 0.00
ArQule (ARQL) United States $0.541B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.538B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.528B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Collegium Pharmaceutical (COLL) United States $0.506B 0.00
Forty Seven (FTSV) United States $0.503B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 27.93
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.458B 0.00
Flexion Therapeutics (FLXN) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
Translate Bio (TBIO) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Aptorum Group (APM) China $0.379B 0.00
ImmunoGen (IMGN) United States $0.374B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
Karyopharm Therapeutics (KPTI) United States $0.335B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Minerva Neurosciences (NERV) United States $0.303B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.289B 0.00
Mast Therapeutics (SVRA) United States $0.287B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Majesco Entertainment (PTE) United States $0.261B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.254B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.248B 0.00
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
HARPOON THERAPT (HARP) United States $0.244B 0.00
Dova Pharmaceuticals (DOVA) United States $0.242B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
ElectroCore (ECOR) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Tyme Technologies (TYME) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Jounce Therapeutics (JNCE) United States $0.202B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Rafael Holdings (RFL) United States $0.188B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Aldeyra Therapeutics (ALDX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.182B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 181.80
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Neon Therapeutics (NTGN) United States $0.146B 0.00
AgeX Therapeutics (AGE) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
Neos Therapeutics (NEOS) United States $0.142B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
MediWound (MDWD) Israel $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.136B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.112B 0.00
DURECT (DRRX) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.102B 0.00
Zafgen (ZFGN) United States $0.100B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.098B 0.00
Infinity Pharmaceuticals (INFI) United States $0.097B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Avenue Therapeutics (ATXI) United States $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.086B 0.00
Otonomy (OTIC) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.081B 7.92
SCYNEXIS (SCYX) United States $0.076B 0.00
Genocea Biosciences (GNCA) United States $0.069B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.058B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Melinta Therapeutics (MLNT) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
NOVAN INC (NOVN) United States $0.036B 0.00
ContraFect (CFRX) United States $0.036B 0.00
Achaogen (AKAO) United States $0.033B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
IsoRay (ISR) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 3.88
Biomerica (BMRA) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
VAXART, INC (VXRT) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00